chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Cough, Headache, Nasal congestion, Oropharyngeal pain
Clinical narrative: sore throat; Congestion; Cough; Headache; body aches; Fever; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot Number: ER8733) via an unspecified route of administration in the arm left on 29Mar2021(at the age of 55-year-old) as a single dose for COVID-19 immunisation. Medical history included back ache, neuropathy, depression, cancer. The patient had allergies to FLAGYL and IV contrast. The patient received unknown concomitant medications. The patient had received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number; EJ1685) vaccine for COVID-19 immunisation on 08Mar2021, in the left arm. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 (Tuesday) about 02:00, the patient woke up with sore throat, congestion, headache, cough. At 06:30, woke up with the same symptoms, in addition, had body aches and fever of 101. Slept off and on. At 06:30, still had all symptoms but fever was 103. The patient called primary physician, but he said was probably side effects, but if condition worsened or had shortness of breath then visit the emergency room, also recommended to get Covid test the next day. Fever broke and by 23:15 was just below 100. Woke up on Wednesday, all symptoms were gone but the cough, some congestion and headache. The patient took Tylenol, and headache went away. The events had not resulted in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events sore throat, headache, body aches and fever was recovered with sequelae. The clinical outcome for congestion and cough was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: sore throat; Congestion; Cough; Headache; body aches; Fever; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot Number: ER8733) via an unspecified route of administration in the arm left on 29Mar2021(at the age of 55-year-old) as a single dose for COVID-19 immunisation. Medical history included back ache, neuropathy, depression, cancer. The patient had allergies to FLAGYL and IV contrast. The patient received unknown concomitant medications. The patient had received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number; EJ1685) vaccine for COVID-19 immunisation on 08Mar2021, in the left arm. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 (Tuesday) about 02:00, the patient woke up with sore throat, congestion, headache, cough. At 06:30, woke up with the same symptoms, in addition, had body aches and fever of 101. Slept off and on. At 06:30, still had all symptoms but fever was 103. The patient called primary physician, but he said was probably side effects, but if condition worsened or had shortness of breath then visit the emergency room, also recommended to get Covid test the next day. Fever broke and by 23:15 was just below 100. Woke up on Wednesday, all symptoms were gone but the cough, some congestion and headache. The patient took Tylenol, and headache went away. The events had not resulted in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events sore throat, headache, body aches and fever was recovered with sequelae. The clinical outcome for congestion and cough was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Axillary pain, Blister, Chills, Dizziness
Clinical narrative: headache; dizziness; fever; chills; Strong stomach pains; nausea; vomiting; distorted taste; new blisters on toes; finger pain; armpit pain; fatigue; brain fog; This is a spontaneous report from a contactable consumer, the patient. A 76-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 10Mar2021 at 16:00 (at the age of 76-year-old) as a single dose for COVID-19 immunisation. The patient was allergic to sulfa drugs, lidocaine, penicillin and mouthwash. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications included aspirin (MANUFACTURER UNKNOWN) 325mg one pill per day. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9269), via an unspecified route of administration in the left arm on 14Feb2021 at 09:45 (at the age of 75-year-old) as single dose for COVID-19 immunisation. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Mar2021 at 08:00 the patient experienced headache, dizziness, fever, chills, strong stomach pain, nausea, vomiting, distorted taste, new blisters on toes, finger pain, armpit pain, fatigue and brain fog. The patient did not receive any treatment for the events. The clinical outcome of the events headache, dizziness, fever, chills, strong stomach pain, nausea, vomiting, distorted taste, new blisters on toes, finger pain, armpit pain, fatigue and brain fog was recovered with sequela on an unknown date in Mar2021.  No follow-up attempts are needed. No further information is expected.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Headache, Nausea, Pain in extremity
Clinical narrative: headache; dizziness; fever; chills; Strong stomach pains; nausea; vomiting; distorted taste; new blisters on toes; finger pain; armpit pain; fatigue; brain fog; This is a spontaneous report from a contactable consumer, the patient. A 76-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 10Mar2021 at 16:00 (at the age of 76-year-old) as a single dose for COVID-19 immunisation. The patient was allergic to sulfa drugs, lidocaine, penicillin and mouthwash. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications included aspirin (MANUFACTURER UNKNOWN) 325mg one pill per day. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9269), via an unspecified route of administration in the left arm on 14Feb2021 at 09:45 (at the age of 75-year-old) as single dose for COVID-19 immunisation. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Mar2021 at 08:00 the patient experienced headache, dizziness, fever, chills, strong stomach pain, nausea, vomiting, distorted taste, new blisters on toes, finger pain, armpit pain, fatigue and brain fog. The patient did not receive any treatment for the events. The clinical outcome of the events headache, dizziness, fever, chills, strong stomach pain, nausea, vomiting, distorted taste, new blisters on toes, finger pain, armpit pain, fatigue and brain fog was recovered with sequela on an unknown date in Mar2021.  No follow-up attempts are needed. No further information is expected.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Taste disorder, Vomiting
Clinical narrative: headache; dizziness; fever; chills; Strong stomach pains; nausea; vomiting; distorted taste; new blisters on toes; finger pain; armpit pain; fatigue; brain fog; This is a spontaneous report from a contactable consumer, the patient. A 76-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 10Mar2021 at 16:00 (at the age of 76-year-old) as a single dose for COVID-19 immunisation. The patient was allergic to sulfa drugs, lidocaine, penicillin and mouthwash. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications included aspirin (MANUFACTURER UNKNOWN) 325mg one pill per day. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9269), via an unspecified route of administration in the left arm on 14Feb2021 at 09:45 (at the age of 75-year-old) as single dose for COVID-19 immunisation. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Mar2021 at 08:00 the patient experienced headache, dizziness, fever, chills, strong stomach pain, nausea, vomiting, distorted taste, new blisters on toes, finger pain, armpit pain, fatigue and brain fog. The patient did not receive any treatment for the events. The clinical outcome of the events headache, dizziness, fever, chills, strong stomach pain, nausea, vomiting, distorted taste, new blisters on toes, finger pain, armpit pain, fatigue and brain fog was recovered with sequela on an unknown date in Mar2021.  No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: both forearms broke out in hives; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the right arm on 30Mar2021 at 13:00 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure. Concomitant medications included losartan (MANUFACTURER UNKNOWN), atorvastatin (MANUFACTURER UNKNOWN) and ascorbic acid (VITAMIN C). The patient had no known allergies to medications, food or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 30Mar2021 at 20:00, approximately seven hours after the injection, the patient's forearms broke out in hives which were still present a full day later. The right arm was far worse than the left. Later, the patient also noticed them on the lower sides of his abdomen. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the event both forearms broke out in hives. The clinical outcome of the event forearms broke out in hives was not resolved at the time of the report.   No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain
Clinical narrative: Sore throat; This is a spontaneous report from a non-contactable consumer, the patient. A 53-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 30Mar2021(at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient was allergic to penicillin, sulfonamide, iodine and contrast media. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, it was unknown whether the patient had been tested for COVID-19 . The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021, the patient experienced the event sore throat. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event sore throat was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: She had a bad reaction and ended up in the Emergency Room after the 2nd shot.; This is a spontaneous report from a contactable Physician and a non-contactable consumer. A female patient of 72 age (age units: unknown) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown, expiry date: unknown) via an unspecified route of administration on an unspecified date (2-3 weeks ago as reported) as DOSE 2, SINGLE for Covid-19 immunization. Patient's medical history and concomitant medications were not reported. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via unspecified route of administration on an unspecified date as DOSE 1, SINGLE for Covid-19 immunization. Patient had a bad reaction and ended up in the Emergency Room after the 2nd shot on an unspecified date. 5 days after she recovered without any issues. The outcome of the event was recovered on an unspecified date.   No follow-up attempts are possible; information about lot/batch cannot be obtained.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Breast pain, Lymphadenopathy, Neck pain, Pain in extremity
Clinical narrative: very large moveable lymph node on left clavicle; whole arm is sore; breast tissue is sore; whole arm and into her breast tissue is sore and into my neck; This is a spontaneous report from a contactable other healthcare professional, the patient. A 58-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 25Mar2021 at 10:30 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included hyperthyroidism, hypertension, cholesterol high, fibromyalgia. The patient had allergy with mold me flex. Concomitant medications received within 2 weeks of vaccination was reported as 'my prescribed meds'. The patient previously received cefaclor (CECLOR) and clarithromycin (BIAXIN), both for an unknown indication and experienced drug allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 30Mar2021 at 16:00, the patient experienced very large moveable lymph node on her left clavicle, whole arm and into her breast tissue were sore and into neck. No therapeutic measures were taken as a result of the reported events. The clinical outcomes of the event very large moveable lymph node on left clavicle, whole arm and into her breast tissue is sore and into neck were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Diarrhoea, Dizziness, Headache
Clinical narrative: Chattering teeth; worst leg aches; worst leg aches and cramps ever; nausea; dizziness; huge headache; low grade fever; diarrhea; This is a spontaneous report from a non-contactable consumer, the patient. A 41-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: UNKNOWN) via an unspecified route of administration in the left arm on 30Mar2021 at 14:00(at the age of 41-year-old) as a single dose for COVID-19 immunisation. No relevant medical history was reported. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) and vitamins for an unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination and since the vaccination, the patient had not been tested for COVID-19. On 30Mar2021, the patient experienced chattering teeth, worst leg aches and cramps, nausea, dizziness, huge headache, low grade fever and diarrhoea. On an unknown date, the patient underwent body temperature measurement and result was found to be 99.6 F. No therapeutic measures were taken for the events. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care The clinical outcome of all the events chattering teeth, worst leg aches and cramps, nausea, dizziness, huge headache, low grade fever and diarrhoea were resolving at the time of the report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms, Nausea, Pain in extremity, Pyrexia
Clinical narrative: Chattering teeth; worst leg aches; worst leg aches and cramps ever; nausea; dizziness; huge headache; low grade fever; diarrhea; This is a spontaneous report from a non-contactable consumer, the patient. A 41-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: UNKNOWN) via an unspecified route of administration in the left arm on 30Mar2021 at 14:00(at the age of 41-year-old) as a single dose for COVID-19 immunisation. No relevant medical history was reported. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) and vitamins for an unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination and since the vaccination, the patient had not been tested for COVID-19. On 30Mar2021, the patient experienced chattering teeth, worst leg aches and cramps, nausea, dizziness, huge headache, low grade fever and diarrhoea. On an unknown date, the patient underwent body temperature measurement and result was found to be 99.6 F. No therapeutic measures were taken for the events. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care The clinical outcome of all the events chattering teeth, worst leg aches and cramps, nausea, dizziness, huge headache, low grade fever and diarrhoea were resolving at the time of the report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Right arm developed an extreme pain; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP 7534), via an unspecified route of administration in the left arm on 19Mar2021 at 14:00 (at the age of 34-years-old), as a single dose for COVID-19 immunisation. Medical history included polycystic ovarian syndrome. The patient had no allergies to medications, food, or other products. The patient did not receive any medications within 2 weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccination. On 20Mar2021, the patient developed an extreme pain in right arm. The patient received vaccine on left arm, however, the next day right arm developed an extreme pain that disabled the patient from using the whole right arm. The pain had lasted for one week. On an unspecified date in Mar2021 (reported as for the past two days), the pain had slowly been wearing off however the patient still had difficulty using the right arm at 100%. This event resulted in doctor or other healthcare professional office/clinic visit. The patient received ibuprofen (MANUFACTURER UNKNOWN) as treatment for the event. The clinical outcome of the event extreme pain in right arm was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Breast pain, Chills, Fatigue, Pain
Clinical narrative: pain all over my body; pain left arm pit; pain in my left breast; Some chill; very fatigue.; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; (Lot Number: EP6955) via an unspecified route of administration in the arm left on 30Mar2021 at 12:15 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism. The patient had a history of allergy to penicillin. Concomitant medications included levothyroxine 100mcg (MANUFACTURER UNKNOWN) from unknown date for unknown indication. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247,) via an unspecified route of administration in the arm left on 09Mar2021 at 09:45 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 31Mar2021 at 00:15, after 12 hours of the second dose, the patient experienced general body pain, the left arm pit area and left breast  (injection arm) and had 8/10 level of pain, chills and very fatigue. The patient did not received any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events general body pain, armpit pain, breast pain, chills and fatigue was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Malaise, Pain, Pain in extremity, Pyrexia
Clinical narrative: Bossy ache; Malaise; Fever; Chills; Sore arm; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA Vaccine; Lot Number: ER8730), via an unspecified route of administration in the left arm on 29Mar2021 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension and atopic dermatitis. The patient did not have any allergies to food, medications, or other products. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA Vaccine; Lot number: EN6206) via an unspecified route of administration in the left arm on 09Mar2021 at 11:45 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Mar2021 at 16:00, the patient experienced malaise, fever, chills, bossy ache and sore arm. The patient did not receive any treatment for the events malaise, fever, chills, bossy ache and sore arm. The clinical outcomes of the events malaise, fever, chills, bossy ache and sore arm were resolving at the time of the report.   No follow-up attempts are needed. No further information is expected.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Heart rate increased, Nausea, Paraesthesia
Clinical narrative: Rapid heartbeat; tingling in hands andarms,; light headedness; dizziness; nausea; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 31Mar2021 at 12:45 (at the age of 41-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not have allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 12:45 the patient experienced rapid heartbeat, tingling in hands and arms, light headedness, dizziness and nausea. The adverse events did not result in consultation to doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcomes of the events of rapid heartbeat, tingling in hands and arms, light headedness, dizziness and nausea was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Feeling abnormal, Lymph node pain, Pain in extremity
Clinical narrative: Pain around the side and back of knee; Left elbow area pain. Believe its the lymph node.; Pain top of left foot.; Feels like bruised, but its not.; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EM9809), via an unspecified route of administration in the left arm on 31Mar2021 at 12:45 (at the age of 59-year-old), as a single dose for COVID-19 immunisation. Medical history included cancer, amputation, cardiomyopathy and fibromyalgia. The patient had no allergies to medications, food or other products. Concomitant medications included heart and pain medication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 16:00, the patient experienced left elbow area, much pain when bending it. The patient reported it was of the lymph node, most definitely not the joint. The patient feels like it was bruised but it was not. Pain around side and back of knee and top of left foot. Not as severe as elbow area. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for feeling abnormal, foot pain, lymph node pain and knee pain. The clinical outcomes of the events feeling abnormal, foot pain, lymph node pain and knee pain was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Genital blister, Genital lesion, Genital ulceration, Skin disorder
Clinical narrative: Superficial Ulcerative genital blistersand lesions; Superficial Ulcerative genital blistersand lesions; broken skin, painful; Superficial Ulcerative genital blistersand lesions; This is a spontaneous report from a contactable other healthcare professional, the patient. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 26Mar2021 at 15:00 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension, and COVID-19 (prior to vaccination). The patient had no known drug allergies (NKDA). The patient did not receive concomitant medications within two weeks of vaccination. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks. On 27Mar2021 at 12:00, the patient experienced superficial ulcerative genital blisters and lesions, and broken skin, which was painful and symptoms were started within 24 hours after the vaccination. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of superficial ulcerative genital blisters and lesions, and broken skin, painful and included lab work drawn, assessment performed, and treatment given with unspecified prescriptions. The clinical outcomes of the events superficial ulcerative genital blisters and lesions, and broken skin, painful were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Asthma, Dyspnoea
Clinical narrative: Triggered an asthmatic response, restricting breathing. Occurred 9 hours after vaccine administration. Solved with prescribed Albuterol inhaler, two puffs of 90mcg spaced 1 minute apart.; Triggered an asthmatic response, restricting breathing. Occurred 9 hours after vaccine administration. Solved with prescribed Albuterol inhaler, two puffs of 90mcg spaced 1 minute apart.; This is a spontaneous report from a contactable consumer (patient) reported for himself. A 23-year-old male patient received first dose of BNT162B2 (PFIZER BioNTech COVID 19 Vaccine, Solution for Injection, Lot number: EP7533), via an unspecified route in the right arm on 31Mar2021 at 09:15, as a single dose for covid-19 immunization. Medical history included asthma and allergies. The patient concomitant medications were not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Post vaccination, patient has not been tested for COVID-19. On 31Mar2021 at 18:15, 9 hours after vaccine administration, patient experienced an asthmatic response and restricting breathing. Therapeutic measures taken as a result of the events included albuterol inhaler, two puffs of 90mcg spaced 1 minute apart. The clinical outcome of the events was recovering at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Oral pain
Clinical narrative: mouth sore; This is a spontaneous report received from a contactable consumer, the patient. A 64-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 25Mar2021 at 18:45 (at the age of 64-year-old) as a single dose for COVID-19 immunisation. Medical history included diabetes. The patient had no known allergies to food, medications, or other products.  The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date, as a single dose for COVID-19 immunisation. The patient received unspecified medications within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 26Mar2021 at 06:00 (the day after second vaccine), the patient experienced mouth sore, which he never had one before. It was reported that the patient's sister did as well and it took one month to go away. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care The patient did not receive any treatment for the reported event. The clinical outcome of the event mouth sore was resolved on an unknown date in Mar2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021366615 Same reporter/ drug/ AE, different patient
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash papular
Clinical narrative: itchy small bumps on my arms and legs. They seemed like bug bites but there were no bugs. It lasted about 2 days.; itchy small bumps on my arms and legs. They were raised but no red.; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep7534) via an unspecified route of administration in the arm left on 22Mar2021 at 17:30 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included psoriasis and psoriatic arthritis. The patient was allergic to chlorhexidine (MANUFACTURER UNKNOWN) and duraprep (MANUFACTURER UNKNOWN). Concomitant medications included minoxidil (MANUFACTURER UNKNOWN), adalimumab (HUMIRA) and finasteride (MANUFACTURER UNKNOWN), all taken for unknown indication, since unspecified dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccine within four weeks prior to COVID-19 vaccine. On 24Mar2021 the patient experienced itchy and rash papular. About 1.5 days after the injection, the patient noticed itchy small bumps on her arms and legs. The patient reported that they seemed like bug bites but there were no bugs. It lasted about 2 days. They were raised but not red. But itched. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Treatment received for the adverse events was reported as no. The clinical outcome of the events itchy and rash papular were recovered on 26Mar2021.  No follow-up attempts are needed. No further information is expected.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Myalgia, Nausea
Clinical narrative: Nausea; Full body muscle ache; Fever; Excessive tiredness; Dizziness; headache; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EP7534) via an unspecified route of administration in the left arm on 29Mar2021 (at the age of 44-year-old) at 17:30 as a single dose for COVID-19 immunisation. Medical history included HIV and obesity. The patient did not have any allergies to medications, food, or other products. Concomitant medications included ergocalciferol 50,000 (MANUFACTURER UNKNOWN), dolutegravir sodium (TIVICAY), emtricitabine, tenofovir alafenamide fumarate (DESCOVY) and fenofibrate (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested with COVID-19. On 30Mar2021 at 02:00, the patient experienced nausea, full body muscle aches, fever, excessive tiredness, dizziness and headache. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events nausea, full body muscle aches, fever, excessive tiredness, dizziness and headache was recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Nausea; Full body muscle ache; Fever; Excessive tiredness; Dizziness; headache; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EP7534) via an unspecified route of administration in the left arm on 29Mar2021 (at the age of 44-year-old) at 17:30 as a single dose for COVID-19 immunisation. Medical history included HIV and obesity. The patient did not have any allergies to medications, food, or other products. Concomitant medications included ergocalciferol 50,000 (MANUFACTURER UNKNOWN), dolutegravir sodium (TIVICAY), emtricitabine, tenofovir alafenamide fumarate (DESCOVY) and fenofibrate (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested with COVID-19. On 30Mar2021 at 02:00, the patient experienced nausea, full body muscle aches, fever, excessive tiredness, dizziness and headache. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events nausea, full body muscle aches, fever, excessive tiredness, dizziness and headache was recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Dehydration, Fatigue, Influenza, Insomnia
Clinical narrative: Dehydration; Symptoms of the flu; Soreness; Unable to sleep; Aches in joints; Nausea; Fever; Tiredness; This is a spontaneous report from a contactable other healthcare professional. A 61-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: er8732) via an unspecified route of administration in the left arm on 30Mar2021 at 13:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: er8732) via an unspecified route of administration in the left arm on an unspecified date in Mar2021 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 the patient experienced dehydration, aches in joints, nausea, fever, soreness, symptoms of the flu, tiredness and unable to sleep. The adverse events did not result in a visit to the doctors or other healthcare professional office or clinic visit and emergency room or department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events dehydration, aches in joints, nausea, fever, soreness, symptoms of the flu, tiredness and unable to sleep were not recovered at the time of this report.     No follow-up attempts are needed. No further information is expected.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Pain, Pyrexia
Clinical narrative: Dehydration; Symptoms of the flu; Soreness; Unable to sleep; Aches in joints; Nausea; Fever; Tiredness; This is a spontaneous report from a contactable other healthcare professional. A 61-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: er8732) via an unspecified route of administration in the left arm on 30Mar2021 at 13:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: er8732) via an unspecified route of administration in the left arm on an unspecified date in Mar2021 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 the patient experienced dehydration, aches in joints, nausea, fever, soreness, symptoms of the flu, tiredness and unable to sleep. The adverse events did not result in a visit to the doctors or other healthcare professional office or clinic visit and emergency room or department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events dehydration, aches in joints, nausea, fever, soreness, symptoms of the flu, tiredness and unable to sleep were not recovered at the time of this report.     No follow-up attempts are needed. No further information is expected.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Nausea
Clinical narrative: Very bad nausea; Dizziness; This is a spontaneous report received from a non-contactable consumer. A 20-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the right arm on 30Mar2021 (at the age of 20-years-old) as a single dose for COVID-19 immunisation. Medical history included the patient was allergic to iodine. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On an unknown date in Mar2021, the patient experienced very bad nausea and dizziness. The patient did not receive any treatment for the adverse events. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the events nausea and dizziness was resolved with lasting effects on unspecified date in Mar2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Burning sensation
Clinical narrative: Burning to the touch sensation in leftleg. From upper groin to bottom of feet; This is a spontaneous report received from a contactable consumer, the patient. A 47-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8730) via an unspecified route of administration in the left arm on 28Mar2021 at 01:30 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included graves' disease. Concomitant medications included thiamazole (METHIMAZOLE) for an unknown indication and from an unknown date. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 29Mar2021 at 04:00, the patient experienced burning to touch sensation in left leg, from upper groin to bottom of feet. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the event burning sensation in left leg from upper groin to bottom of feet was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, SARS-CoV-2 test
Clinical narrative: Chills; This is a spontaneous report from a contactable consumer, the patient. A 72-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EL9267) via unspecified route of administration in the left arm on 12Feb2021 at 11:00 (at the age of 72-years-old) as a single dose for COVID-19 immunisation. The patient's medical history included hoshimotos disease, blood pressure high and osteopenia. The patient had a known allergy to penicillin. The patient concomitant medications included rosuvastatin (MANUFACTURER UNKNOWN), telmisartan (MANUFACTURER UNKNOWN) and Metoprolol succinate (TOPROL-XL) received within 2 weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EL3247) via unspecified route of administration in the left arm on 22Jan2021 at 11:00 (at the age of 72-years-old) as single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. On 15Feb2021, the patient experienced chills 2 days after the second vaccination with 2 hours of duration and had it for every two to three days since last 7 weeks approximately and sometimes more than once a day/ night. On 10Mar2021, the patient underwent COVID-19 test (nasal swab) and the result was negative. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of chills. The clinical outcome of the event chills was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Ear infection, Ear pain, Inflammation, Middle ear effusion, SARS-CoV-2 test
Clinical narrative: Ear infection; Ear was slightly tender; Scrating caused it to become inflamed; Ear hurts; Ear is now filled with fluids; This is a spontaneous report from a non-contactable consumer, the patient. A 23-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8732), via an unspecified route of administration in the left arm on 24Mar2021 (at the age of 23-year-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no allergies to medications, food, or other products. Concomitant medications included minoxidil (ROGAINE) and multivitamin (MANUFACTURER UNKNOWN); both taken for unknown indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021 at 20:00 the patient experienced ear infection. The patient did not leave the house and had not interacted with anyone. The patient noticed that ear was slightly tender and had agitated by scratching which caused it to become inflamed. The patient reported that ear was filled with fluids and that it hurt. The patient experienced ear infection frequently when patient had cold, and thought the vaccine made his body to react in the same way. On 29Mar2021, the patient was tested for COVID-19 virus test which resulted in negative. The adverse event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of ear infection, tenderness, inflammation, ear pain and fluid in middle ear which included treatment with amoxicillin (MANUFACTURER UNKNOWN). The clinical outcomes of the events ear infection, tenderness, inflammation, ear pain and fluid in middle ear were resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.